Mark Mallon Email and Phone Number
Chief Executive Officer
at
Neogenomics Laboratories
Mark Mallon's email is mark.mallon2@astrazeneca.com
and
Mark Mallon's phone number is +9714-362-4888
.
Mark Mallon Contact Details
Email
mark.mallon2@astrazeneca.com
Email
mark.mallon@astrazeneca.com
Email
mark.mallon@astrazeneca-us.com
Email
mark.mallon@neogenomics.com
Phone
+9714-362-4888
Mark Mallon Company Details
Location
Fort Myers, Florida, United States
Industry
Hospital & Health Care
Mark Mallon's Current Company
Neogenomics Laboratories
|
|
Industry | Hospital & Health Care |
|
|
Location | Fort Myers, Florida, United States |
|
|
Industry | Hospital & Health Care |
|
|
Location | Fort Myers, Florida, United States |
Mark Mallon's Experience and Education
Work Experience
Marketing Director Gi Therapeutic Area, Us Business
1999-01 to 1999-12
Cambridge, Cambridgeshire, United Kingdom
Customer Unit Director North Illinois, Wisconsin, Michigan, Minnesota, And North Dakota
1998-01 to 1998-12
Cambridge, Cambridgeshire, United Kingdom
Director Of Promotions Prilosec
1997-03 to 1997-12
Cambridge, Cambridgeshire, United Kingdom
Director Managed Care Promotions
1994-06 to 1997-03
Cambridge, Cambridgeshire, United Kingdom
Chief Executive Officer
2021-03 to Unknown
Fort Myers, Florida, United States
Executive Vice President, Global Product And Portfolio Strategy, Medical Affairs And Corp Affairs
2016-08 to 2019-01
Cambridge, Cambridgeshire, United Kingdom
Assistant Research And Development
1987-09 to 1988-05
Lancaster, Pennsylvania, United States
President, Astrazeneca China
2011-04 to 2011-11
Cambridge, Cambridgeshire, United Kingdom
Chief Operations Officer, Azkk Japan
2009-04 to 2011-04
Cambridge, Cambridgeshire, United Kingdom
Vice President Of Marketing And Sales Ops
2006-01 to 2009-03
Cambridge, Cambridgeshire, United Kingdom
Marketing Company President Italy
2004-01 to 2005-09
Cambridge, Cambridgeshire, United Kingdom
Vice President, Gi Therapeutic Area, Us Business
2000 to 2003
Cambridge, Cambridgeshire, United Kingdom
Executive Senior Advisor To The Board And Future Chief Executive Officer
2019-01-21 to 2019-04
Boston, Massachusetts, United States
Regional Vice President Asia Pacific And President China
2011-11-01 to 2012-12-01
Cambridge, Cambridgeshire, United Kingdom
Chief Executive Officer And Member Of Board Of Directors
2019-04 to 2021-03
Boston, Massachusetts, United States
Executive Vice President, International
2013-01-01 to 2016-04
Cambridge, Cambridgeshire, United Kingdom
Education
Bachelor Of Science in Chemical Engineering
1980-01-01 to 1984
Philadelphia, Pennsylvania, United States
Frequently Asked Questions about Mark Mallon
What company does Mark Mallon work for?
Mark Mallon works for Neogenomics Laboratories
What is Mark Mallon's role in his workplace?
Mark Mallon's role in his workplace is
Chief Executive Officer .
Which industry does Mark Mallon work in currently?
Mark Mallon works in the industry
Hospital & Health Care.
What is Mark Mallon's email address?
Mark Mallon's email address is mark.mallon2@astrazeneca.com
What is Mark Mallon's direct phone number?
Mark Mallon's direct phone number is +9714-362-4888
What schools did Mark Mallon attended?
Mark Mallon attended
University Of Pennsylvania,
and
The Wharton School.
What are some of Mark Mallon's skills?
Mark Mallon has skills like
Pharmaceutical Industry,
Sales Operations,
Leadership,
Marketing,
Cross Functional Team Leadership,
Product Launch,
Pharmaceutical Sales,
Sales,
Sales Effectiveness,
Strategy,
Biotechnology,
Global Marketing,
Commercialization,
Oncology,
Managed Care,
Cardiology,
Market Access,
Market Analysis,
Medical Devices,
Healthcare,
and
Clinical Development.
Who are Mark Mallon's colleagues?
Mark Mallon's colleagues are
Cqpa Jennifer Walsh,
Anna Gaede,
Nicholas Kalogeras,
Kimberly Howard,
Adriana Hsu,
J Timothy Cunagin,
and
Kayla Forte.
Who are Mark Mallon's peers at other companies?
Mark Mallon's peers at other companies are
Riccardo Muzzi,
Syed Rehman,
Leo Friedman,
Larmender Davis,
Vince Pestano,
Tkachenko Gennadevich,
and
Okoroafor Ngozi.
